Stopped: Met futility threshold at interim analysis
This study aims to evaluate the utility of long-acting liposomal bupivacaine (Exparel®) in improving pain scores and reducing narcotic pain requirements in pediatric patients following minor urologic procedures.
Age range
6 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Percentage of Patients Who Are Opiate-free
Timeframe: 48 hours postoperatively
Percentage of Patients Who Are Opiate-free at 10-14 Days Postoperatively
Timeframe: 10-14 days postoperatively
Parents' Postoperative Pain Measure (PPPM) Scores
Timeframe: 48 hours postoperatively
Parents' Postoperative Pain Measure (PPPM) Scores
Timeframe: 10-14 days postoperatively